Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [543]
News [1580]
Articles [79]
Editorials [2]
Conferences [74]
elearning [5]

Benefit and risk analysis from the phase III OPTiM trial

Dr Kevin Harrington - Institute of Cancer Research, London, UK
Benefit and risk analysis from the phase III OPTiM trial ( Dr Kevin Harrington - Institute of Cancer Research, London, UK )
5 Nov 2015

Progress in targeted therapy of melanoma

Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA
Progress in targeted therapy of melanoma ( Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA )
5 Nov 2015

Metastatic melanoma: Patient-reported outcomes from the KEYNOTE-002 study

Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany
Metastatic melanoma: Patient-reported outcomes from the KEYNOTE-002 study ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )
5 Nov 2015

Melanoma prevention: Do we need sunlight for vitamin D?

Prof Julia A Newton-Bishop - University of Leeds, Leeds, UK
Melanoma prevention: Do we need sunlight for vitamin D? ( Prof Julia A Newton-Bishop - University of Leeds, Leeds, UK )
5 Nov 2015

Why is screening for melanoma important?

Prof Iris Zalaudek - Medical University of Graz, Graz, Austria
Why is screening for melanoma important? ( Prof Iris Zalaudek - Medical University of Graz, Graz, Austria )
5 Nov 2015

Management of acute metastatic melanoma

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK
Management of acute metastatic melanoma ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )
5 Nov 2015

How should we handle talimogene laherparepvec (T-VEC)?

Prof Axel Hauschild - University of Kiel, Kiel, Germany
How should we handle talimogene laherparepvec (T-VEC)? ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
5 Nov 2015

New challenges in drug combination and strategies

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK
New challenges in drug combination and strategies ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )
5 Nov 2015

Targeting N-RAS mutated tumours

Prof Axel Hauschild - University of Kiel, Kiel, Germany
Targeting N-RAS mutated tumours ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
30 Oct 2015

HVEM expression in melanoma metastasis: prognosis correlation

Prof Daniel Olive - Marseilles Cancer Research Center, Marseilles, France
HVEM expression in melanoma metastasis: prognosis correlation ( Prof Daniel Olive - Marseilles Cancer Research Center, Marseilles, France )
30 Oct 2015

Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma

Prof Axel Hauschild - University of Kiel, Kiel, Germany
Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
30 Oct 2015

Systemic immunotherapy and radiotherapy combination shows promise in advanced skin cancer

Dr Susan Hiniker - Stanford University, Stanford, USA
Systemic immunotherapy and radiotherapy combination shows promise in advanced skin cancer ( Dr Susan Hiniker - Stanford University, Stanford, USA )
27 Oct 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation